Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FML0M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,298
Award facts
- Contract value 100% obligated
- $20,298.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,298.48 delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen (semaglutide), a GLP-1 receptor agonist medication used for weight management. This non-set-aside, firm fixed-price delivery order was issued on February 2, 2026, with an ultimate completion date of February 3, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora Inc. (formerly AmerisourceBergen), is a major pharmaceutical distributor providing critical medical commodities to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and veterans' healthcare programs. The parent company Cencora also maintains a separate $999.99 million IDC with DLA Troop Support Medical extending through December 2031, reflecting the company's substantial role in supporting military healthcare logistics globally. This delivery order for Zepbound exemplifies the ongoing procurement of specialty medications through the DLA's established pharmaceutical supply chain partnerships.
Quick answers
Who was awarded contract SPE2DR26FML0M?
SPE2DR26FML0M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FML0M worth?
The government has obligated $20,298 on SPE2DR26FML0M.
Is contract SPE2DR26FML0M an order under another contract?
Yes. SPE2DR26FML0M is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FML0M competed?
The extent of competition for SPE2DR26FML0M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award